Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 6.27% is 24% below its 5-year average of 8.30%, near the low end of its 5-year range (5.39%–14.66%).
9.04% above its 12-month average of 5.75%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
6.27%
RETURN ON ASSETS (ROA) AVG TTM
5.75%
RETURN ON ASSETS (ROA) AVG 3Y
6.24%
RETURN ON ASSETS (ROA) AVG 5Y
8.30%
RETURN ON ASSETS (ROA) AVG 10Y
7.64%
RETURN ON ASSETS (ROA) AVG 15Y
6.70%
RETURN ON ASSETS (ROA) AVG 20Y
7.20%
CURRENT VS TTM AVG
+9.04%
CURRENT VS 3Y AVG
+0.48%
CURRENT VS 5Y AVG
-24.49%
CURRENT VS 10Y AVG
-17.94%
CURRENT VS 15Y AVG
-6.42%
CURRENT VS 20Y AVG
-12.95%
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+26.92%
vs the sector median at left
Quest Diagnostics Incorporated
Market Cap
$26.23B
Return on Assets (ROA)
6.27%
TTM Avg
5.75%
3Y Avg
6.24%
5Y Avg
8.30%
Market Cap
$26.35B
Return on Assets (ROA)
5.41%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
Market Cap
$24.78B
Return on Assets (ROA)
13.86%
TTM Avg
12.54%
3Y Avg
14.20%
5Y Avg
14.86%
Market Cap
$24.64B
Return on Assets (ROA)
20.48%
TTM Avg
9.54%
3Y Avg
8.43%
5Y Avg
7.44%
Market Cap
$28.59B
Return on Assets (ROA)
2.47%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
Market Cap
$23.73B
Return on Assets (ROA)
-28.75%
TTM Avg
-24.02%
3Y Avg
-10.32%
5Y Avg
-0.33%
Market Cap
$28.85B
Return on Assets (ROA)
24.67%
TTM Avg
25.02%
3Y Avg
24.63%
5Y Avg
23.85%
Market Cap
$29.03B
Return on Assets (ROA)
14.54%
TTM Avg
-0.12%
3Y Avg
-10.91%
5Y Avg
-15.37%
Market Cap
$23.31B
Return on Assets (ROA)
-6.03%
TTM Avg
-3.96%
3Y Avg
9.16%
5Y Avg
17.06%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $26.23B | 6.27% | 5.75% | 6.24% | 8.30% |
| Labcorp Holdings Inc. (LH)vs › | $26.35B | 5.41% | 4.41% | 4.42% | 6.18% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.78B | 13.86% | 12.54% | 14.20% | 14.86% |
| Incyte Corporation (INCY)vs › | $24.64B | 20.48% | 9.54% | 8.43% | 7.44% |
| Medline Inc. (MDLN)vs › | $28.59B | 2.47% | 3.17% | 1.75% | 1.75% |
| Moderna, Inc. (MRNA)vs › | $23.73B | -28.75% | -24.02% | -10.32% | -0.33% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.85B | 24.67% | 25.02% | 24.63% | 23.85% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.03B | 14.54% | -0.12% | -10.91% | -15.37% |
| BioNTech SE (BNTX)vs › | $23.31B | -6.03% | -3.96% | 9.16% | 17.06% |
| STERIS plc (STE)vs › | $23.28B | 5.64% | 6.68% | 4.44% | 4.33% |
ROA
6.3%
ROE
14.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 6.11% |
| 2024-12-31 | 5.39% |
| 2023-12-31 | 6.09% |
| 2022-12-31 | 7.37% |
| 2021-12-31 | 14.66% |
| 2020-12-31 | 10.20% |
| 2019-12-31 | 6.68% |
| 2018-12-31 | 6.69% |
| 2017-12-31 | 7.35% |
| 2016-12-31 | 6.39% |
| 2015-12-31 | 7.12% |
| 2014-12-31 | 5.63% |
| 2013-12-31 | 9.49% |
| 2012-12-31 | 5.99% |
| 2011-12-31 | 5.05% |
| 2010-12-31 | 8.45% |
| 2009-12-31 | 8.51% |
| 2008-12-31 | 6.92% |
| 2007-12-31 | 3.97% |
| 2006-12-31 | 10.36% |
| 2005-12-31 | 10.30% |
| 2004-12-31 | 11.87% |
| 2003-12-31 | 10.15% |
| 2002-12-31 | 9.69% |
| 2001-12-31 | 5.54% |
| 2000-12-31 | 3.56% |
| 1999-12-31 | -0.12% |
| 1998-12-31 | 1.98% |
| 1997-12-31 | -1.59% |
| 1996-12-31 | -44.87% |
